Degarelix: a guide to its use in advanced prostate cancer

By Lyseng-Williamson Katherine A.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 5, 2012-05 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite

Triptorelin embonate (6-month formulation): a guide to its use in advanced prostate cancer

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 6, 2010-06 ,pp. : 5-7

Adis International

Access to resources Recommend Favorite

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer

By Hatoum Hind T   Crawford E David   Nielsen Sandy Kildegaard   Lin Swu-Jane   Marshall Dennis C  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 261-270

Informa Healthcare

Access to resources Recommend Favorite

Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer

By Scott Lesley J.   Yang Lily P.H.   Lyseng-Williamson Katherine A.  

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

Degarelix less costly than goserelin for prostate cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite